Observing heart failure patients with BIOTRONIK CRT devices
Official title: Observation of Clinical Routine Care for Heart Failure Patients Implanted With BIOTRONIK CRT Devices
Run by Biotronik SE & Co. KG · NCT03366545 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study looks at how well cardiac resynchronization therapy (CRT) works for heart failure patients by tracking their progress with new or upgraded devices over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 3000 (estimated) |
| Sponsor | Biotronik SE & Co. KG Industry-sponsored |
| Locations | 121 sites (Canberra and 120 other locations) |
| Trial ID | NCT03366545 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include heart failure patients who are undergoing a planned de novo implantation or upgrade to a CRT system and are willing to participate in remote monitoring.
✕Probably not a fit
Patients who have contraindications for CRT, are under 18 years old, or are already implanted with a CRT system may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to assess the outcomes and efficacy of cardiac resynchronization therapy (CRT) in heart failure patients through long-term data collection in a real-life clinical setting. It focuses on understanding patient status to identify predictors for heart failure events and areas for improvement in CRT device settings. The study involves monitoring patients who are newly implanted with or upgraded to a CRT system, utilizing remote monitoring technology for data collection.
Why it matters
Potential benefit: If successful, this study could enhance the management and treatment outcomes for heart failure patients receiving CRT.
How similar studies have gone: Other studies have shown success with similar observational approaches in assessing CRT outcomes, indicating potential for valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Planned de novo implantation of or upgrade to a CRT system for treatment according to the intended use * Patient is able to understand the nature of the registry and has provided written informed consent * Patient is willing and able to use the CardioMessenger and accepts the Home Monitoring concept * Remote monitoring using the Home Monitoring® platform is planned for the patient Exclusion Criteria: * Standard contraindication for CRT * Already or previously implanted with CRT system * • Age \< 18 years * Participation in another interventional clinical investigation other than the registry-based trials of BIO\|STREAM.HF * Pregnant or breastfeeding
Where it's running
-
CHU de Brest
Brest, France Recruiting -
Le Centre Hospitalier Universitaire de CAEN
Caen, France Recruiting -
Hôpital Privé / Institute Jaques Cartier
Massy, France Recruiting -
Clinique les Fontaines
Melun, France Recruiting -
CHU Montpellier
Montpellier, France Recruiting -
Hôpital privé du Confluent
Nantes, France Recruiting
Show 44 more locations
-
Hopital Pitie-Salpetriere
Paris, France Recruiting -
Centre Hospitalier Mémorial de Saint-Lô
Saint-Lô, France Recruiting -
Centre Hospitalier Universitaire de Saint-Étienne
Saint-Étienne, France Recruiting -
Hôpitaux Universitaires de Strasbourg
Strasbourg, France Recruiting -
Chru de Tours
Tours, France Recruiting -
CH de Valence
Valence, France Recruiting -
Canberra Heart Rhythm Foundation
Canberra, Australia Terminated -
The Canberra Hospital
Canberra, Australia Terminated -
Lyell McEwin Hospital
Elizabeth Vale, Australia Terminated -
Liverpool Hospital
Liverpool, Australia Terminated -
Sydney Adventist Hospital
Sydney, Australia Completed -
Westmead Hospital
Westmead, Australia Terminated -
Westmead Private Hosptial
Westmead, Australia Terminated -
Kepler Universitätsklinikum
Linz, Austria Terminated -
Universitätsklinikum St. Pölten
St. Polten, Austria Terminated -
Medizinische Universität Wien
Vienna, Austria Terminated -
Imelda Ziekenhuis
Bonheiden, Belgium Terminated -
UZ Brussel
Brussels, Belgium Terminated -
CHR de la Citadelle - Liège
Liège, Belgium Terminated -
Fakultní nemocnice Olomouc
Olomouc, Czechia Active not recruiting -
Institute for Clinical and Experimental Medicine (IKEM)
Praha, Czechia Active not recruiting -
Nemocnice České Budějovice
České Budějovice, Czechia Active not recruiting -
Centre Hospitalier Louis Pasteur
Chartres, France Terminated -
CHU Dupuytren Limoges
Limoges, France Withdrawn -
CH Saint Philibert
Lomme, France Active not recruiting -
Centre Hospitalier Lorient
Lorient, France Active not recruiting -
Hopital de la Croix Rousse
Lyon, France Withdrawn -
Hôpital privé Clairval
Marseille, France Terminated -
Hopital de la Timone (CHU La Timone)
Marseille, France Active not recruiting -
Clinique du Millenaire
Montpellier, France Terminated -
Hôpital Haut Lévêque
Pessac Cedex, France Terminated -
Centre Hospitalier de Périgeux
Périgueux, France Terminated -
Centre Hospitalier de Rangueil
Toulouse, France Terminated -
Clinique Pasteur Toulouse
Toulouse, France Terminated -
Centre Hospitalier Bretagne Atlantique Prosper Chubert
Vannes, France Terminated -
Städtisches Klinikum St.Georg
Leipzig, Sachsen, Germany Completed -
Zentralklinik Bad Berka GmbH
Bad Berka, Germany Terminated -
HDZ Bad Oeynhausen
Bad Oeynhausen, Germany Terminated -
Maria Heimsuchung - Carita-Klinik Pankow
Berlin, Germany Active not recruiting -
Städtisches Klinikum Brandenburg GmbH
Brandenburg, Germany Terminated -
Krankenhaus Buchholz und Winsen AöR
Buchholz, Germany Active not recruiting -
Universitätsklinikum Erlangen
Erlangen, Germany Active not recruiting -
Universitätsklinikum Giessen und Marburg
Gießen, Germany Active not recruiting -
KMG Klinikum Güstrow
Güstrow, Germany Terminated
+71 more sites. See ClinicalTrials.gov for the full list.
Study contacts
- Study coordinator: Maria Jung, Dr.
- Email: bio-stream-hf@biotronik.com
- Phone: +493068905
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.